We are live on
!
Find out more
ABMD
Abiomed Inc
ABMD
ABMD
Delisted
ABMD was delisted on the 21st of December, 2022.
527 hedge funds and large institutions have $16B invested in Abiomed Inc in 2018 Q2 according to their latest regulatory filings, with 153 funds opening new positions, 157 increasing their positions, 171 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
428% more first-time investments, than exits
New positions opened: 153 | Existing positions closed: 29
40% more funds holding in top 10
Funds holding in top 10: 15 → 21 (+6)
40% more capital invested
Capital invested by funds: $11.5B → $16B (+$4.55B)
30% more funds holding
Funds holding: 405 → 527 (+122)
8% less repeat investments, than reductions
Existing positions increased: 157 | Existing positions reduced: 171
21% less call options, than puts
Call options by funds: $167M | Put options by funds: $212M
Holders
527
Holders Change
+122
Holders Change %
+30.12%
% of All Funds
12.07%
Holding in Top 10
21
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+40%
% of All Funds
0.48%
New
153
Increased
157
Reduced
171
Closed
29
Calls
$167M
Puts
$212M
Net Calls
-$45.4M
Net Calls Change
-$39.3M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$297M |
| 2 |
Two Sigma Advisers
New York
|
+$210M |
| 3 |
State Street
Boston,
Massachusetts
|
+$158M |
| 4 |
Renaissance Technologies
New York
|
+$146M |
| 5 |
Two Sigma Investments
New York
|
+$138M |
